What is best practice when it comes to patient consent? - Hamilton Fraser

Guide

Valid patient consent starts with a conversation. Before agreeing to an aesthetic treatment, a patient needs to understand what it involves, what it could achieve, the risks that matter to them and their other options. A signature records a decision; it cannot replace the discussion that makes that decision informed.

For practitioners, a clear consent process supports patient safety and realistic expectations. It also creates a record of what was discussed if concerns arise later. This guide explains how to put consent into practice, from the first consultation to repeat treatments and aftercare.

What makes patient consent valid

Consent must be voluntary and informed, and the person giving it must have capacity to make the particular decision. Start from the presumption that an adult has capacity. If there are concerns, assess the specific decision at the relevant time and follow the law that applies where you practise. Do not proceed with elective treatment simply because a form has been signed.

Patients need information in a form they can understand, time to consider it and freedom from pressure. Offer communication support where needed, such as an interpreter or accessible written information. Check understanding through conversation rather than asking only whether they have read the form.

Explaining material risks and reasonable alternatives

The principle established in Montgomery v Lanarkshire Health Board in 2015 remains relevant: patients should be made aware of material risks and reasonable alternatives. A risk is material if a reasonable person in that patient’s position would consider it significant, or the practitioner knows or should know that this particular patient would.

This does not mean reciting every conceivable complication. Explain recognised risks, serious harms even where unlikely, and risks that matter because of the patient’s circumstances. For example, visible bruising may be particularly important to someone whose work involves public appearances. Ask what outcomes or recovery effects would influence their decision.

The Supreme Court’s 2023 McCulloch judgment clarified that identifying reasonable alternative treatments involves professional judgment supported by a responsible body of medical opinion. It did not remove the duty to discuss reasonable alternatives. In aesthetics, include the option of no treatment and explain if another suitable approach could meet the patient’s needs with less risk.

Professional consent standards for aesthetic practitioners

Aesthetic treatments are provided by practitioners from different professional backgrounds. Registered healthcare professionals must follow the consent standards of their own regulator alongside the law that applies to their practice. 

GMC guidance for doctors

The GMC’s decision-making and consent guidance took effect in 2020 and has since been updated. Its cosmetic-interventions guidance adds requirements specific to cosmetic practice. Doctors should read both; practitioners registered with other regulators must also follow their own professional standards.

For cosmetic interventions, the GMC places responsibility for discussing the procedure and seeking consent on the medical professional performing it, or supervising its performance. This responsibility must not be delegated to a patient adviser or administrative team. The discussion should explore the patient’s reasons for treatment, expected outcome, psychological needs and whether the intervention is appropriate.

Read the GMC’s guidance on seeking consent for cosmetic interventions

‍NMC standards for nurses and midwives

The NMC Code requires nurses, midwives and nursing associates to obtain properly informed consent and document it before carrying out any action. It also requires them to respect a person’s right to accept or refuse treatment and follow the relevant mental capacity law.

For independent nurse and midwife prescribers, an additional requirement has applied since 1 June 2025: they must carry out a face-to-face consultation and document an appropriate clinical assessment before prescribing medicines for elective non-surgical cosmetic procedures. This includes relevant anti-wrinkle medicines and aesthetic emergency kit items. Remote methods, including video calls, are not sufficient. The NMC’s position covers initial and subsequent consultations and follow-ups. The prescriber remains responsible for informed consent, suitability assessment and explaining risks and benefits; an in-person appointment alone does not establish valid consent.

Read Hamilton Fraser’s explanation of the NMC’s cosmetic prescribing requirements.

GDC standards and non-surgical cosmetic practice

Principle 3 of the GDC’s Standards for the dental team requires valid consent before treatment, sufficient information and time to decide, checks on understanding, and records of the discussion. Consent must remain valid at each stage of care.

Importantly, the GDC recently changed its scope of practice for dental professionals, stating that non-surgical cosmetic procedures such as botulinum toxin and dermal filler treatments are not considered the practice of dentistry. 

This does not amount to a blanket ban on dental professionals providing them. Those who do must evidence appropriate training, competence and indemnity or insurance, and remain accountable to the GDC. The GDC expects its professional standards to be upheld when registrants provide non-surgical cosmetic treatments, although it does not issue procedure-specific standards for this work.

Read Hamilton Fraser’s explanation of the GDC scope of practice position.

GPhC guidance for pharmacy professionals

The General Pharmaceutical Council’s In practice: Guidance on consent, updated in May 2025, sets out pharmacy professionals’ legal and professional duty to obtain consent for the services, treatment and care they provide. It emphasises capacity, voluntary decisions, balanced information about material risks and alternatives, and checking understanding. Consent must be revisited on each occasion rather than presumed from a previous treatment.

The guidance also addresses using and sharing patient information. Consent to treatment should not be treated as permission for every use of that information; follow confidentiality and data protection requirements, including identifying an appropriate legal basis for processing.

10 practical tips for taking patient consent

1.     Use treatment-specific information

Tailor the discussion and documentation to the proposed procedure and the individual patient. A generic tick-box form may prompt a conversation, but it will not capture every personal concern, medical factor or treatment limitation.

2.     Explore expectations and suitability

Ask what the patient wants to change and why. Explain likely results and limitations without promising a particular outcome. If treatment is unlikely to benefit them, explain your reasoning and decline where appropriate. Consent does not make unsuitable treatment appropriate.

3.     Discuss benefits, risks and alternatives

Explain the proposed treatment, material risks, likely recovery and reasonable alternatives, including doing nothing. Be clear about uncertainty, the possibility of an unsatisfactory result and any further treatment that may be needed.

4.     Give time for reflection

The GMC does not prescribe one cooling-off period for every cosmetic procedure. Allow time appropriate to the intervention’s invasiveness, complexity, permanence and risks, and the patient’s needs. Follow any additional professional or policy requirements. Avoid time-limited offers that pressure patients to proceed.

5.     Check understanding and willingness

Invite questions and ask the patient to explain their understanding of the proposed treatment and its main risks. Confirm that the decision is their own. If they will not engage in an adequate discussion, record this and defer treatment rather than relying on a signature.

6.     Explain aftercare and costs before treatment

Discuss recovery, warning signs, follow-up arrangements and who to contact with concerns. Give written aftercare information. Explain what the quoted fee includes and any possible additional charges, including for follow-up or revision treatment.

7.     Record the conversation and the decision

Keep clear clinical notes of the options, individual risks, questions, answers and agreed plan. Record the patient’s consent and use a signed, dated treatment-specific form in line with your policy requirements. Retain copies or identifiable versions of information supplied.

8.     Review consent at each treatment appointment

Do not assume an earlier signature covers every future procedure. Reconfirm willingness to proceed and check for changes in health, medication, expectations or treatment risks. Update the discussion and documentation, and complete fresh forms where your policy or procedure requires them.

9.     Seek permission before contacting the GP

Consider whether information from the patient’s GP is needed to assess risks and benefits. Seek the patient’s permission. If they refuse, discuss and record their reasons and consider whether you can safely proceed without that information.

10.  Stay within the agreed treatment plan

Consent to one procedure does not authorise an additional treatment or a material change. Discuss changes and obtain valid consent before proceeding. If the patient withdraws consent, stop as safely as possible, explain any immediate safety needs and document what happened.

Why good consent records matter for insurance

If a complaint or claim arises, records help explain what information the patient received and how the treatment decision was reached. A signed form alone may not show that a particular risk or alternative was discussed. Record the patient’s concerns and your responses while the conversation is fresh.

Check your insurance requirements for consent documentation, photographs and record retention. If a patient raises a concern that could lead to a claim, notify your insurer promptly in line with your policy rather than waiting for a solicitor’s letter. Hamilton Fraser customers can contact the cosmetic claims team on 0345 310 6335.

For help responding to concerns, read our guide to handling complaints effectively.

Frequently asked questions

Do consent requirements apply to nurses, dentists and pharmacists in aesthetics?

Yes. Valid consent is required regardless of the practitioner’s professional background. Nurses and midwives must follow the NMC Code, dental professionals the GDC’s standards, and pharmacy professionals the GPhC’s requirements. Additional prescribing rules may also apply. Professional registration or a signed form does not replace an individual discussion about the proposed treatment.

What does the GMC say about consent for cosmetic procedures?

The GMC says the medical professional performing or supervising a cosmetic intervention must discuss it with the patient and seek consent personally. Patients need information about benefits, risks, limitations and alternatives, sufficient reflection time and freedom from pressure. Their expectations, psychological needs and right to change their mind must also be considered.

What does the GDC say about consent for aesthetic treatments?

The GDC requires dental professionals to obtain valid consent, explain options and risks, check understanding and document discussions. Consent must remain valid throughout treatment. Although non-surgical cosmetic injectables are outside the practice of dentistry, dental professionals providing them remain accountable to the GDC and must uphold its professional standards.

What does the NMC say about consent for aesthetic treatments?

The NMC Code requires informed consent to be obtained and documented before treatment, with the patient’s right to refuse respected. Since 1 June 2025, independent nurse and midwife prescribers must also conduct face-to-face consultations and document clinical assessments before prescribing medicines for elective non-surgical cosmetic procedures. Video consultations are insufficient.

What does the GPhC say about consent for aesthetic treatments?

The GPhC requires pharmacy professionals to obtain valid consent for the care, treatment and services they provide. Patients must have capacity, decide voluntarily and receive understandable information about material risks and reasonable alternatives. Consent is an ongoing process: practitioners should check understanding, record decisions appropriately and revisit consent on each occasion.

What are the top tips for taking valid patient consent?

Make consent a personalised conversation. Check capacity and willingness, explain benefits, material risks and reasonable alternatives, and give time for reflection. Invite questions, check understanding and record the discussion alongside the patient’s decision. Review consent before treatment and whenever circumstances change; a signed form does not replace meaningful dialogue.

Is there a fixed cooling-off period for aesthetic treatments?

The GMC does not specify a single cooling-off period for all cosmetic interventions. Reflection time should reflect the treatment’s invasiveness, complexity, permanence and risks, alongside the patient’s needs and previous information. Follow any additional requirements from your professional body, clinic or insurer, and avoid pressuring patients into same-day treatment.

Do you need new consent for repeat aesthetic treatments?

Review consent before every treatment, even when a patient has had the procedure before. Check for changes in their health, medication, expectations, treatment plan or risk information. Record the review and any updated discussion. Complete fresh consent forms where required by your insurer or clinic procedure; an old signature is not blanket permission.

‍

‍

Get a quote today!
We’ve made the process easy